Premium
Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading
Author(s) -
Katabi Nora,
Ghossein Ronald,
Ali Safina,
Dogan Snjezana,
Klimstra David,
Ganly Ian
Publication year - 2014
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/his.12488
Subject(s) - desmoplasia , grading (engineering) , mucoepidermoid carcinoma , pleomorphism (cytology) , medicine , pathology , necrosis , carcinoma , radiology , biology , immunohistochemistry , stroma , ecology
Aims To compare the different grading systems of mucoepidermoid carcinoma ( MEC ) and identify the most reliable and objective histopathologic features predictive of outcome. Methods and results Seventy‐two cases diagnosed as MEC were subjected to a meticulous histopathologic re‐review. 20 of 72 (28%) cases were originally misdiagnosed as MEC including 16 as high grade ( HG ). Among the 52 confirmed MEC , median follow up ( FU ) was 59 months. Mitosis (≥4/10 High Power Fields), necrosis, pleomorphism, focal keratinization, desmoplasia, and lymph node metastasis were associated with adverse disease specific survival ( DSS ) and recurrence free survival ( RFS ) ( P < 0.002). In all grading systems, low and intermediate grade had similar DSS and RFS but much better outcome than HG ( P < 0.007). All patients with tumour harboring low mitotic rate and no necrosis did not recur except for one patient with a positive margin. All cases with high mitotic rate and necrosis died or recurred. Conclusions The majority of previously diagnosed HG MEC cases are misclassified. There is no difference in outcome between low and intermediate grade in all grading schemes. Consideration should be given to stratify MEC based on relatively objective criteria such as mitosis and necrosis.